Will Texas go it alone by giving stem cell clinics free rein or will it break new ground by passing laws that promote reasonable stem cell clinical practices with safeguards? Some middle ground? It’s a dramatic moment for the stem cell field as legislation under consideration in Texas could have big impact on stem cell businesses […]
Battle over Texas stem cell legislation flares as it nears end Read More »
Should there be a religious or moral litmus test for the NIH Director? A few dozen super conservative Republican members of Congress have written a letter to President Trump saying he should fire NIH Director Francis Collins. Why? Because they claim that Collins is not conservative enough for their taste and in particular they don’t
GOP reps to Trump: fire NIH Director Collins for stem cell research support Read More »
It’s fun and useful for me to learn about the readers of this blog in terms of who they are and what their interests are in terms of the types of posts that I do. Below are the results of two recent reader surveys that I did to get this kind of information. The two
Blog reader survey results & winner of the stem cell swag Read More »
Enjoy! A Sunday brunch for the brain of science news, helpful links, and notable new papers including on stem cells. News and links CBER Director Focuses on Flexibility to Advance Regenerative Medicines Lab-Grown Blood Stem Cells Produced at Last Transplanted stem cells become eggs in sterile mice Maryland fund awards $8.5 million for stem cell research Positively good news from Asterias
Stem cells Sunday brunch of good news, fun links, & cool papers Read More »
I’ve been working on a stem cells in many languages outreach program I call the Knoepfler Lab Stem Cell Outreach Program for Education (SCOPE). The idea behind SCOPE is to make available on the Internet a basic page of facts about stem cells in as many languages as possible. Our motto could be articulated as “Stem
SCOPE 2017: learn about stem cells in your own language Read More »
The Texas Legislature is considering three risky bills that would give free rein to stem cell clinics to profit big time off of patients by selling unproven and unapproved “stem cell treatments” that have little if any science behind them. I call one of these bills “Right to Profit” for clinics, which if these became
Risky Pro-Stem Cell Clinic Bills Still Alive in Texas Legislature Read More »
Every few years I do a survey of you guys so I can have a better sense of my blog’s readership. For that purpose, below I’ve got two polls to ask you (1) about your general backgrounds and (2) preferences about post content. Because some people may want to vote more than once on the
Stem Cell Blog Reader Survey, Free Swag Read More »
Where is the field of IPS cells going and how will this impact the overall field of stem cell-based regenerative medicine? Nobel Laureate Shinya Yamanaka, the discoverer of IPS cells, gave a really interesting recent interview to Nikkei that provides some fascinating insights into the future of this exciting technology that is now more than a decade
New Yamanaka interview gives key insights into future of IPS cells Read More »
The 21st Century Cures Act has some important regenerative medicine language in it. One part of that was attempting to accelerate FDA review of promising investigation regenerative medicine therapies. The mechanism for this was a new designation called Regenerative Advanced Therapy, now renamed Regenerative Medicine Advanced Therapy (RMAT) Designation. I don’t think anyone was sure
Big change for stem cell field with FDA quickly issuing RMATs Read More »
Today’s post is the last of a three-part series on the Burt stem cell trials at Northwestern. This piece is focused on funding and the future of the trial, and also includes perspectives from patients. You can read Part 1 here and Part 2 here, which focused on issues related to potential encouragement of patient fundraising that unintentionally releases
Burt Northwestern Stem Cell MS Trial Part 3: Funding, Patient Perspectives, & the Future Read More »